These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Approaches to the patient with neurogenetic disease. Bird TD Clin Lab Med; 2010 Dec; 30(4):785-93. PubMed ID: 20832652 [TBL] [Abstract][Full Text] [Related]
5. [Introduction to neurogenetics]. Klein C; Gasser T Nervenarzt; 2013 Feb; 84(2):135-6. PubMed ID: 23354822 [No Abstract] [Full Text] [Related]
6. Introduction to Neurogenetics. Vgontzas A; Renthal W Am J Med; 2019 Feb; 132(2):142-152. PubMed ID: 30098310 [TBL] [Abstract][Full Text] [Related]
7. [Main trends in clinical neurogenetics (problems of diagnosis, pathogenesis and treatment of hereditary diseases of the nervous system)]. Shmidt EV; Tkachev RA; Markova ED Vestn Akad Med Nauk SSSR; 1986; (9):13-8. PubMed ID: 3788269 [No Abstract] [Full Text] [Related]
8. Databases for neurogenetics: introduction, overview, and challenges. Sobrido MJ; Cacheiro P; Carracedo A; Bertram L Hum Mutat; 2012 Sep; 33(9):1311-4. PubMed ID: 22890789 [TBL] [Abstract][Full Text] [Related]
9. [Key problems of clinical neurogenetics]. Shmidt EV; Tkachev RA; Markova ED Vestn Akad Med Nauk SSSR; 1976; (7):84-90. PubMed ID: 800312 [No Abstract] [Full Text] [Related]
10. Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions. Laskowitz DT; Vitek MP Pharmacogenomics; 2007 Aug; 8(8):959-69. PubMed ID: 17716229 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility genes and neurological disorders: learning the right lessons from the human genome project. Grodin MA; Laurie GT Arch Neurol; 2000 Nov; 57(11):1569-74. PubMed ID: 11074788 [No Abstract] [Full Text] [Related]
12. Clinical approach to the patient with neurogenetic disease. Bird TD; Smith CO Handb Clin Neurol; 2018; 147():3-9. PubMed ID: 29325619 [TBL] [Abstract][Full Text] [Related]
13. [Genetic markers in neuropsychiatric disorders: genetic mapping and diagnostic and therapeutic prospectives (I)]. Cacabelos R Med Clin (Barc); 1992 Oct; 99(13):505-14. PubMed ID: 1434976 [No Abstract] [Full Text] [Related]
14. Neurogenetics in art. Emery AE Int Rev Neurobiol; 2006; 74():235-40. PubMed ID: 16730517 [No Abstract] [Full Text] [Related]
15. Genomics and medicine. Dissecting human disease in the postgenomic era. Peltonen L; McKusick VA Science; 2001 Feb; 291(5507):1224-9. PubMed ID: 11233446 [No Abstract] [Full Text] [Related]
16. Genome editing technologies and their potential to treat neurologic disease. Madigan NN; Staff NP; Windebank AJ; Benarroch EE Neurology; 2017 Oct; 89(16):1739-1748. PubMed ID: 28931646 [No Abstract] [Full Text] [Related]
17. Whole genome expression as a quantitative trait. Hardy J; Trabzuni D; Ryten M Biochem Soc Trans; 2009 Dec; 37(Pt 6):1276-7. PubMed ID: 19909261 [TBL] [Abstract][Full Text] [Related]
18. [Achievements and perspectives in the control of diseases of the nervous system]. Shmidt EV Klin Med (Mosk); 1976 Sep; 54(9):5-12. PubMed ID: 187833 [No Abstract] [Full Text] [Related]
19. The next epidemic. Petsko GA Genome Biol; 2006; 7(5):108. PubMed ID: 16737558 [TBL] [Abstract][Full Text] [Related]
20. Novel etiological and therapeutic strategies for neurodiseases: preface. Ikegaya Y; Suzuki T J Pharmacol Sci; 2010; 113(1):1-2. PubMed ID: 20424391 [No Abstract] [Full Text] [Related] [Next] [New Search]